Biocapital: The Constitution of Postgenomic LifeDuke University Press, 2006 M04 24 - 360 páginas Biocapital is a major theoretical contribution to science studies and political economy. Grounding his analysis in a multi-sited ethnography of genomic research and drug development marketplaces in the United States and India, Kaushik Sunder Rajan argues that contemporary biotechnologies such as genomics can only be understood in relation to the economic markets within which they emerge. Sunder Rajan conducted fieldwork in biotechnology labs and in small start-up companies in the United States (mostly in the San Francisco Bay area) and India (mainly in New Delhi, Hyderabad, and Bombay) over a five-year period spanning 1999 to 2004. He draws on his research with scientists, entrepreneurs, venture capitalists, and policymakers to compare drug development in the two countries, examining the practices and goals of research, the financing mechanisms, the relevant government regulations, and the hype and marketing surrounding promising new technologies. In the process, he illuminates the global flow of ideas, information, capital, and people connected to biotech initiatives. Sunder Rajan’s ethnography informs his theoretically sophisticated inquiry into how the contemporary world is shaped by the marriage of biotechnology and market forces, by what he calls technoscientific capitalism. Bringing Marxian theories of value into conversation with Foucaultian notions of biopolitics, he traces how the life sciences came to be significant producers of both economic and epistemic value in the late twentieth century and early twenty-first. |
Dentro del libro
Resultados 1-3 de 87
Página 187
... structure of miracle , a structure , further , that is founded on the inadequacy of previous therapies ( even though they too were once miracles ) . It is a structure of linear progress that is embedded and embodied in specific ...
... structure of miracle , a structure , further , that is founded on the inadequacy of previous therapies ( even though they too were once miracles ) . It is a structure of linear progress that is embedded and embodied in specific ...
Página 279
... structure and instead to proliferate ac- counts of the fragments that constitute ( and , indeed , exceed and surprise ) such structures . Rabinow , then , proposes a way to account for epochs , for those concepts of structure that structure ...
... structure and instead to proliferate ac- counts of the fragments that constitute ( and , indeed , exceed and surprise ) such structures . Rabinow , then , proposes a way to account for epochs , for those concepts of structure that structure ...
Página 308
... structures that provide the agent who hails with authority , and make the agent hailed a subject to the voice ... structure , which is expressed here through an abstraction ) . 23. And even if one were paid " enough , " the nature ...
... structures that provide the agent who hails with authority , and make the agent hailed a subject to the voice ... structure , which is expressed here through an abstraction ) . 23. And even if one were paid " enough , " the nature ...
Contenido
Contradictions in Market Logic | 39 |
Ecologies of Biocapital | 77 |
The Conjuration | 107 |
Derechos de autor | |
Otras 6 secciones no mostradas
Otras ediciones - Ver todas
Términos y frases comunes
actors American analysis Andhra Pradesh argue articulation big pharmaceutical biocapital Biocon bioinformatics biological biopolitical biotech biotech companies biotechnology Brahmachari business models Celera Celera Genomics chapter clinical trials commodity consequence constitute context corporate course CSIR culture discourse disease DNA chip DNA sequence dot.com drug development emergent entrepreneurs epistemic ethical ethnographic exchange fetishism forms free market future GeneEd GeneEd's Genentech genetic genome companies global high-tech human genome Hyderabad hype ideology Incyte India Indian innovation instance institutional intellectual property investment investors involved labor market logic Marx material Maulik mutant Naidu Parel particular Patel patent personalized medicine pharmaceutical companies pharmacogenomics population potential production promissory question regimes relationship Rep-X risk salvationary scientific fact scientists Scott Silicon Valley specific start-up story strategic structure surplus value technoscience technoscientific tion United venture capital venture capitalists venture science vision words
Referencias a este libro
The Logic of Care: Health and the Problem of Patient Choice Annemarie Mol Sin vista previa disponible - 2008 |